(-0.01%) 5 099.22 points
(0.17%) 38 306 points
(-0.04%) 15 922 points
(-1.34%) $82.73
(6.24%) $2.04
(0.03%) $2 347.90
(-0.27%) $27.46
(3.79%) $957.05
(-0.18%) $0.933
(-0.28%) $10.99
(-0.50%) $0.796
(1.75%) $93.48
3 days till quarter result
(bmo 2024-05-02)
Expected move: +/- 8.20%
Live Chart Being Loaded With Signals
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally...
Stats | |
---|---|
Dagens volum | 44 406.00 |
Gjennomsnittsvolum | 241 301 |
Markedsverdi | 3.55B |
EPS | $0 ( 2024-02-08 ) |
Neste inntjeningsdato | ( $1.140 ) 2024-05-02 |
Last Dividend | $0.475 ( 2018-09-27 ) |
Next Dividend | $0 ( N/A ) |
P/E | -43.33 |
ATR14 | $0.0680 (0.10%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-01 | Fritz Mary Beth | Buy | 110 | Common Stock, par value $0.01 per share |
2024-03-01 | Fritz Mary Beth | Buy | 62 | Common Stock, par value $0.01 per share |
2024-03-01 | Fritz Mary Beth | Sell | 62 | Common Stock, par value $0.01 per share |
2024-03-01 | Fritz Mary Beth | Sell | 110 | Common Stock, par value $0.01 per share |
2024-03-01 | Fritz Mary Beth | Sell | 62 | Employee Stock Options (right to buy) |
INSIDER POWER |
---|
-21.28 |
Last 99 transactions |
Buy: 327 711 | Sell: 471 882 |
Volum Korrelasjon
Prestige Consumer Korrelasjon
10 Mest positive korrelasjoner |
---|
10 Mest negative korrelasjoner |
---|
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Prestige Consumer Korrelasjon - Valuta/Råvare
Prestige Consumer Økonomi
Annual | 2023 |
Omsetning: | $1.13B |
Bruttogevinst: | $625.29M (55.45 %) |
EPS: | $-1.650 |
FY | 2023 |
Omsetning: | $1.13B |
Bruttogevinst: | $625.29M (55.45 %) |
EPS: | $-1.650 |
FY | 2022 |
Omsetning: | $1.09B |
Bruttogevinst: | $620.65M (57.11 %) |
EPS: | $4.09 |
FY | 2021 |
Omsetning: | $943.37M |
Bruttogevinst: | $547.47M (58.03 %) |
EPS: | $3.28 |
Financial Reports:
No articles found.
Prestige Consumer Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $0.475 | 2018-09-27 |
Last Dividend | $0.475 | 2018-09-27 |
Next Dividend | $0 | N/A |
Payout Date | 2018-10-15 | |
Next Payout Date | N/A | |
# dividends | 1 | -- |
Total Paid Out | $0.475 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 1.21 | -- |
Div. Sustainability Score | 6.61 | |
Div.Growth Potential Score | 1.411 | |
Div. Directional Score | 4.01 | -- |
Year | Amount | Yield |
---|---|---|
2018 | $0.475 | 1.08% |
2019 | $0 | 0.00% |
2020 | $0 | 0.00% |
2021 | $0 | 0.00% |
2022 | $0 | 0.00% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
LOMA | Dividend Knight | 2023-06-30 | Quarterly | 2 | 5.23% | 8.53 |
SBR | Dividend Royal | 2023-11-14 | Monthly | 38 | 7.74% | 8.50 |
MTR | Dividend Diamond | 2023-10-30 | Monthly | 39 | 10.10% | 8.50 |
PDI | Dividend Royal | 2023-11-10 | Monthly | 13 | 7.86% | 8.50 |
ZTR | Dividend King | 2024-02-09 | Monthly | 37 | 8.35% | 8.50 |
ORC | Dividend Royal | 2023-11-29 | Monthly | 12 | 9.23% | 8.50 |
NCZ | Dividend Royal | 2024-02-09 | Monthly | 22 | 7.79% | 8.50 |
KIO | Dividend Royal | 2023-12-14 | Monthly | 12 | 7.05% | 8.50 |
SCM | Dividend King | 2023-12-15 | Monthly | 13 | 7.08% | 8.50 |
SJT | Dividend Royal | 2023-11-29 | Monthly | 39 | 12.52% | 8.50 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.0711 | 1.500 | -1.422 | -2.13 | [0 - 0.5] |
returnOnAssetsTTM | -0.0242 | 1.200 | -0.805 | -0.966 | [0 - 0.3] |
returnOnEquityTTM | -0.0532 | 1.500 | -1.702 | -2.55 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 3.09 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 1.867 | 0.800 | 3.72 | 2.98 | [0.8 - 2.5] |
cashRatioTTM | 0.499 | 1.500 | 8.34 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.363 | -1.500 | 3.94 | -5.92 | [0 - 0.6] |
interestCoverageTTM | 4.94 | 1.000 | 9.28 | 9.28 | [3 - 30] |
operatingCashFlowPerShareTTM | 4.85 | 2.00 | 8.38 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 4.67 | 2.00 | 7.67 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.758 | -1.500 | 6.97 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.552 | 1.000 | 4.13 | 4.13 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.309 | 1.000 | 5.83 | 5.83 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.199 | 1.000 | -0.00777 | -0.00777 | [0.2 - 2] |
assetTurnoverTTM | 0.340 | 0.800 | -1.069 | -0.855 | [0.5 - 2] |
Total Score | 6.61 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -43.45 | 1.000 | -4.49 | 0 | [1 - 100] |
returnOnEquityTTM | -0.0532 | 2.50 | -1.094 | -2.55 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 4.67 | 2.00 | 8.44 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 4.85 | 2.00 | 8.38 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -0.0857 | 1.500 | -3.90 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.212 | 1.000 | 7.19 | 0 | [0.1 - 0.5] |
Total Score | 1.411 |
Prestige Consumer
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.